Financial statements Animal Pharma Lublin-Kruszyński,Pieczkowski,Rapkowski,
Balance sheet data of ANIMAL PHARMA LUBLIN-KRUSZYŃSKI,PIECZKOWSKI,RAPKOWSKI,
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|
Total assets | 8 002 732,37 | 12 977 350,86 | 13 150 325,38 | 14 217 743,47 | 16 307 552,06 |
A. Fixed assets | 2 200 080,36 | 2 070 582,85 | 1 643 754,59 | 869 381,01 | 721 340,32 |
B. Current assets | 5 802 652,01 | 10 906 768,01 | 11 506 570,79 | 13 348 362,46 | 15 586 211,74 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 8 002 732,37 | 12 977 350,86 | 13 150 325,38 | 14 217 743,47 | 16 307 552,06 |
A. Equity | 2 983 617,49 | 10 543 681,74 | 6 591 242,54 | 4 252 378,15 | 8 771 539,58 |
B. Liabilities and provisions for liabilities | 5 019 114,88 | 2 433 669,12 | 6 559 082,84 | 9 965 365,32 | 7 536 012,48 |
I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
II. Short-term liabilities | 5 019 114,88 | 2 421 895,91 | 6 559 082,84 | 9 965 365,32 | 7 536 012,48 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.